New vaccine shows promise in battling recurrent brain tumors

NCT ID NCT04116658

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a new vaccine called EO2401 in 100 adults with glioblastoma that had come back after standard treatment. The vaccine was given alone or with other drugs to see if it was safe and could help the immune system fight the cancer. The goal was to find better ways to control this aggressive brain tumor.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GLIOBLASTOMA, ADULT are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

adult glioblastoma glioblastoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Centre Georges François Leclerc

    Dijon, 21000, France

  • Dana Farber Cancer Institute

    Boston, Massachusetts, 02215, United States

  • Hospital Universitari Vall d'Hebron

    Barcelona, 08035, Spain

  • Hôpital Pitié-Salpétrière

    Paris, 75013, France

  • Institit Catala D'Oncologia - Hospital Duran i Reynals

    L'Hospitalet de Llobregat, 8908, Spain

  • Klinik und Poliklinik für Neurologie Universitätsklinikum Bonn

    Bonn, 53105, Germany

  • Medizinische Fakultät Mannheim der Universität Heidelberg

    Mannheim, 68167, Germany

  • Neurologische Klinik & Nationales Zentrum für Tumorenerkrankungen Heidelberg Universitätsklinikum Heidelberg

    Heidelberg, 69120, Germany

  • Universitätsklinikum Frankfurt Goethe-Universität Dr. Senckenbergisches Institut für Neuroonkologie

    Frankfurt am Main, 60528, Germany

  • Zentrum für Neuroonkologie Universitätsklinikum Tübingen

    Tübingen, 72076, Germany